FII limit to be increased to 31.5%; QIP issue up to Rs 450 crore
Natco Pharma announced that Foreign Investment Promotion Board (FIPB) has approved both of its Foreign Direct Investment (FDI) related proposals in its 221st Meeting held on 13 July 2015.The two approvals given are for:-
1) Increase of Foreign Investment Limit from 24% to 31.5% of the paid up equity share capital of the company.
2) Issue and Allotment of Eligible Securities to Qualified Institutional Buyers (QIBs) up to Rs.450 crore.
Powered by Capital Market - Live News
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app